Display options
Share it on

Indian J Pharm Sci. 2015 May-Jun;77(3):249-57. doi: 10.4103/0250-474x.159596.

Role of Components in the Formation of Self-microemulsifying Drug Delivery Systems.

Indian journal of pharmaceutical sciences

A K Gurram, P B Deshpande, S S Kar, Usha Y Nayak, N Udupa, M S Reddy

Affiliations

  1. Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal-576 104, India.
  2. Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal-576 104, India.

PMID: 26180269 PMCID: PMC4502138 DOI: 10.4103/0250-474x.159596

Abstract

Pharmaceutical research is focused in designing novel drug delivery systems to improve the bioavailability of poorly water soluble drugs. Self-microemulsifying drug delivery systems, one among the lipid-based dosage forms were proven to be promising in improving the oral bioavailability of such drugs by enhancing solubility, permeability and avoiding first-pass metabolism via enhanced lymphatic transport. Further, they have been successful in avoiding both inter and intra individual variations as well as the dose disproportionality. Aqueous insoluble drugs, in general, show greater solubility in lipid based excipients, and hence they are formulated as lipid based drug delivery systems. The extent of solubility of a hydrophobic drug in lipid excipients i.e. oil, surfactant and co-surfactant (components of self-microemulsifying drug delivery systems) greatly affects the drug loading and in producing stable self-microemulsifying drug delivery systems. The present review highlighted the influence of physicochemical factors and structural features of the hydrophobic drug on its solubility in lipid excipients and an attempt was made to explore the role of each component of self-microemulsifying drug delivery systems in the formation of stable microemulsion upon dilution.

Keywords: Lipid based delivery systems; electrostatic interaction; interfacial tension; partition coefficient; solubility

References

  1. J Pharm Sci. 1999 Oct;88(10):1058-66 - PubMed
  2. Eur J Pharm Biopharm. 2000 Jul;50(1):179-88 - PubMed
  3. Adv Drug Deliv Rev. 2000 Dec 6;45(1):89-121 - PubMed
  4. Crit Rev Ther Drug Carrier Syst. 2001;18(1):77-140 - PubMed
  5. AAPS PharmSciTech. 2002;3(4):E35 - PubMed
  6. Biomed Pharmacother. 2004 Apr;58(3):173-82 - PubMed
  7. Mol Pharm. 2006 Nov-Dec;3(6):631-43 - PubMed
  8. Adv Colloid Interface Sci. 2006 Dec 21;128-130:47-64 - PubMed
  9. Eur J Pharm Sci. 2007 Aug;31(5):249-61 - PubMed
  10. Int J Pharm. 2007 Dec 10;345(1-2):9-25 - PubMed
  11. Adv Drug Deliv Rev. 2008 Mar 17;60(6):734-46 - PubMed
  12. Adv Drug Deliv Rev. 2008 Mar 17;60(6):625-37 - PubMed
  13. Adv Drug Deliv Rev. 2008 Mar 17;60(6):638-56 - PubMed
  14. Adv Drug Deliv Rev. 2008 Mar 17;60(6):617-24 - PubMed
  15. AAPS J. 2007 Oct 26;9(3):E344-52 - PubMed
  16. Int J Pharm. 2008 May 1;355(1-2):19-30 - PubMed
  17. AAPS PharmSciTech. 2008;9(2):628-34 - PubMed
  18. Eur J Pharm Biopharm. 2009 Feb;71(2):310-7 - PubMed
  19. Adv Drug Deliv Rev. 2008 Dec 14;60(15):1663-73 - PubMed
  20. AAPS PharmSciTech. 2009;10(3):906-16 - PubMed
  21. Drug Discov Today. 2009 Nov;14(21-22):1067-74 - PubMed
  22. J Control Release. 2010 Feb 25;142(1):22-30 - PubMed
  23. Int J Pharm. 2010 Aug 16;395(1-2):154-60 - PubMed
  24. J Pharm Pharmacol. 2010 Dec;62(12):1685-96 - PubMed
  25. Drug Dev Ind Pharm. 2011 Oct;37(10):1225-30 - PubMed
  26. Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):923-42 - PubMed
  27. Int J Pharm. 2011 Nov 25;420(1):1-10 - PubMed
  28. Int J Pharm. 2011 Nov 28;420(2):251-5 - PubMed
  29. Drug Dev Ind Pharm. 2012 Jul;38(7):883-92 - PubMed
  30. J Nanobiotechnology. 2014 Sep 24;12:39 - PubMed
  31. Int J Nanomedicine. 2014 Oct 28;9:4991-9 - PubMed
  32. Int Sch Res Notices. 2014 Dec 08;2014:964051 - PubMed
  33. J Pharm Sci. 1998 Jan;87(1):109-16 - PubMed

Publication Types